Tea Reljic

Ms. Tea Reljic

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2014 in Transplantation and Cellular Therapy
Verified
Journal Article
Open access
IAIman Abu-Dalle
Iman Abu-Dalle
TRTea Reljic
Tea Reljic
TNTaiga Nishihori
Taiga Nishihori
AAAhmad Antar
Ahmad Antar
Ali BazarbachiAli Bazarbachi
Ali Bazarbachi
MKMohamed A. Kharfan-Dabaja
Mohamed A. Kharfan-Dabaja
Acute and chronic graft-versus-host disease (GVHD) remain major obstacles for successful allogeneic hematopoietic cell transplantation. Extracorporeal photopheresis (ECP) modulates immune cells, such as alloreactive T cells and dendritic cells, and improves GVHD target organ function(s) in steroid-refractory GVHD patients. We performed a systematic review to evaluate the totality of evidence regarding the efficacy of ECP for treatment of acute and chronic steroid-refractory or steroid-dependent GVHD. Nine studies, including 1 randomized controlled trial, met inclusion criteria, with a total of 323 subjects. In pooled analyses, overall response rates (ORR) were .69 (95% confidence interval [CI], .34 to .95) and .64 (95% CI, .47 to .79) for acute and chronic GVHD, respectively. In acute GVHD organ-specific responses, ECP resulted in the highest ORR for cutaneous, with .84 (95% CI, .75 to .92), followed by gastrointestinal with .65 (95% CI, .52 to .78). Similar response rates were seen in chronic GVHD involving the skin and gastrointestinal tract. Conversely, ORR for chronic GVHD involving the lungs was only .15 (95% CI, 0 to .5). In chronic GVHD, grades 3 to 4 adverse events were reported at .38 (95% CI, .06 to .78). ECP-related mortality rates were extremely low. Rates of immunosuppression discontinuation were .55 (95% CI, .40 to .70) and .23 (95% CI, .07 to .44) for acute and chronic GVHD, respectively. In summary, albeit limited by numbers of available studies, pooled analyses of prospective studies demonstrate encouraging responses after ECP treatment in acute and chronic GVHD after failing corticosteroids. Further research efforts are needed to improve organ-specific responses.

20 December 2011 in Leukemia
Verified
Journal Article
Closed access
PDF file
AKA Kumar
A Kumar
AMA R Mhaskar
A R Mhaskar
TRTea Reljic
Tea Reljic
RMR S Mhaskar
R S Mhaskar
MKM A Kharfan-Dabaja
M A Kharfan-Dabaja
BDB Djulbegovic
B Djulbegovic

5 June 2014 in BMC Medical Informatics and Decision Making
Verified
Journal Article
Open access
PDF file
BDBenjamin Djulbegovic
Benjamin Djulbegovic
SEShira Elqayam
Shira Elqayam
TRTea Reljic
Tea Reljic
IHIztok Hozo
Iztok Hozo
BMBranko Miladinovic
Branko Miladinovic
JCJanice Cannon-Bowers
Janice Cannon-Bowers
According to the threshold model, when faced with a decision under diagnostic uncertainty, physicians should administer treatment if the probability of disease is above a specified threshold and withhold treatment otherwise. The objectives of the present study are to a) evaluate if physicians act according to a threshold model, b) examine which of the existing threshold models [expected utility theory model (EUT), regret-based threshold model, or dual-processing theory] explains the physicians’ decision-making best.

22 September 2018 in Journal of Clinical Epidemiology
Verified
Journal Article
Closed access
SLShelly-Anne Li
Shelly-Anne Li
PAPaul E. Alexander
Paul E. Alexander
TRTea Reljic
Tea Reljic
ACAdam Cuker
Adam Cuker
RNRobby Nieuwlaat
Robby Nieuwlaat
BDBenjamin Djulbegovic
Benjamin Djulbegovic

16 November 2018 in Bone Marrow Transplantation
Verified
Journal Article
Closed access
PDF file
AKAmbuj Kumar
Ambuj Kumar
TRTea Reljic
Tea Reljic
MHMehdi Hamadani
Mehdi Hamadani
MMMohamad Mohty
Mohamad Mohty
MKMohamed A. Kharfan-Dabaja
Mohamed A. Kharfan-Dabaja

1 December 2013 in Clinical Lymphoma Myeloma and Leukemia
Verified
Journal Article
Closed access
VDVu H. Duong
Vu H. Duong
KLKaren Lin
Karen Lin
TRTea Reljic
Tea Reljic
AKAmbuj Kumar
Ambuj Kumar
NANajla H. Al Ali
Najla H. Al Ali
RKRami S. Komrokji
Rami S. Komrokji